• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富亮氨酸重复激酶 2 相关帕金森病的心率变异性。

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.

机构信息

Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.

The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.

出版信息

Mov Disord. 2017 Apr;32(4):610-614. doi: 10.1002/mds.26896. Epub 2017 Jan 10.

DOI:10.1002/mds.26896
PMID:28071824
Abstract

BACKGROUND

Heart rate variability is reduced in idiopathic PD, indicating cardiac autonomic dysfunction likely resulting from peripheral autonomic synucleinopathy. Little is known about heart rate variability in leucine-rich repeat kinase 2-associated PD.

OBJECTIVES

This study investigated heart rate variability in LRRK2-associated PD.

METHODS

Resting electrocardiograms were obtained from 20 individuals with LRRK2-associated PD, 37 nonmanifesting carriers, 48 related noncarriers, 26 idiopathic PD patients, and 32 controls. Linear regression modelling compared time and frequency domain values, adjusting for age, sex, heart rate, and disease duration.

RESULTS

Low-frequency power and the ratio of low-high frequency power were reduced in idiopathic PD versus controls (P < .008, P < .029 respectively). In contrast, individuals with LRRK2-associated PD were not statistically different from controls in any parameter measured. Furthermore, all parameters trended toward being higher in LRRK2-associated PD when compared with idiopathic PD.

CONCLUSIONS

Heart rate variability may remain intact in LRRK2-associated PD, adding to a growing literature supporting clinical-pathologic differences between LRRK2-associated and idiopathic PD. © 2017 International Parkinson and Movement Disorder Society.

摘要

背景

特发性帕金森病患者的心率变异性降低,表明心脏自主神经功能障碍可能是由于外周自主神经突触核蛋白病引起的。关于富亮氨酸重复激酶 2 相关帕金森病患者的心率变异性知之甚少。

目的

本研究旨在探讨富亮氨酸重复激酶 2 相关帕金森病患者的心率变异性。

方法

从 20 名富亮氨酸重复激酶 2 相关帕金森病患者、37 名非表现性携带者、48 名相关非携带者、26 名特发性帕金森病患者和 32 名对照者中获得静息心电图。通过线性回归模型比较时间和频域值,调整年龄、性别、心率和疾病持续时间。

结果

与对照组相比,特发性帕金森病患者的低频功率和低高频功率比降低(P < .008,P < .029)。相比之下,LRRK2 相关帕金森病患者在任何测量参数上均与对照组无统计学差异。此外,与特发性帕金森病相比,LRRK2 相关帕金森病患者的所有参数均呈升高趋势。

结论

LRRK2 相关帕金森病患者的心率变异性可能保持完整,这增加了越来越多的支持 LRRK2 相关帕金森病和特发性帕金森病之间临床病理差异的文献。

相似文献

1
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.富亮氨酸重复激酶 2 相关帕金森病的心率变异性。
Mov Disord. 2017 Apr;32(4):610-614. doi: 10.1002/mds.26896. Epub 2017 Jan 10.
2
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.富含亮氨酸重复激酶 2 相关帕金森病中心血管迷走神经活动标志物增加。
Clin Auton Res. 2019 Dec;29(6):603-614. doi: 10.1007/s10286-019-00632-w. Epub 2019 Aug 23.
3
Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.富含亮氨酸重复激酶2(LRRK2)突变携带者的脑脊液生物标志物与临床特征
Mov Disord. 2016 Jun;31(6):906-14. doi: 10.1002/mds.26591. Epub 2016 Apr 4.
4
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.与LRRK2相关的帕金森病和特发性帕金森病的运动及非运动异质性
Mov Disord. 2016 Aug;31(8):1192-202. doi: 10.1002/mds.26614. Epub 2016 Apr 19.
5
Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.LRRK2 G2019S 帕金森病非帕金森亲属的运动和非运动特征聚类:一项多中心家族研究。
Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.
6
Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.无症状富含亮氨酸重复激酶2突变携带者的外周炎症增加。
Mov Disord. 2016 Jun;31(6):889-97. doi: 10.1002/mds.26529. Epub 2016 Feb 25.
7
Arm swing as a potential new prodromal marker of Parkinson's disease.手臂摆动作为帕金森病一种潜在的新前驱标志物。
Mov Disord. 2016 Oct;31(10):1527-1534. doi: 10.1002/mds.26720.
8
Heart rate variability and sympathetic skin response for the assessment of autonomic dysfunction in leucine-rich repeat kinase 2 associated Parkinson's disease.心率变异性和交感皮肤反应评估富含亮氨酸重复激酶 2 相关帕金森病的自主神经功能障碍。
Neurophysiol Clin. 2022 Feb;52(1):81-93. doi: 10.1016/j.neucli.2021.12.007. Epub 2022 Jan 19.
9
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.LRRK2 突变型帕金森病患者、特发性帕金森病患者和非患者对照的癌症结局。
Mov Disord. 2019 Sep;34(9):1392-1398. doi: 10.1002/mds.27807. Epub 2019 Jul 26.
10
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.通过问卷调查评估的G2019S LRRK2突变型帕金森病患者及其携带者的快速眼动睡眠行为障碍。
Mov Disord. 2015 Nov;30(13):1834-9. doi: 10.1002/mds.26413. Epub 2015 Sep 14.

引用本文的文献

1
Dysautonomia in Parkinson's Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control.帕金森病中的自主神经功能障碍:葡萄糖脑苷脂酶基因突变对心血管自主神经控制的影响。
Front Neurosci. 2022 Mar 15;16:842498. doi: 10.3389/fnins.2022.842498. eCollection 2022.
2
Heart Rate Variability Analyses in Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病的心率变异性分析:一项系统评价与荟萃分析
Brain Sci. 2021 Jul 21;11(8):959. doi: 10.3390/brainsci11080959.
3
Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.
心率短期减速能力:特发性帕金森病中心脏自主神经功能障碍的敏感标志物。
Clin Auton Res. 2021 Dec;31(6):729-736. doi: 10.1007/s10286-021-00815-4. Epub 2021 Jul 12.
4
Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration.壁细胞:弥合心血管疾病和神经退行性变的潜在治疗靶点。
Cells. 2021 Mar 8;10(3):593. doi: 10.3390/cells10030593.
5
Genetic and Environmental Factors Influence the Pleomorphy of Parkinsonism.遗传和环境因素影响帕金森病的多态性。
Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045.
6
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.富含亮氨酸重复激酶 2 相关帕金森病中心血管迷走神经活动标志物增加。
Clin Auton Res. 2019 Dec;29(6):603-614. doi: 10.1007/s10286-019-00632-w. Epub 2019 Aug 23.
7
Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke.房颤相关性卒中的潜在生物标志物和治疗靶点的生物信息学基因分析。
J Transl Med. 2019 Feb 13;17(1):45. doi: 10.1186/s12967-019-1790-x.